Skip to main content
. 2014 Jul 4;8(4):791–806. doi: 10.1177/1932296814536271

Table 4.

Construction of the Reduced Dynamic Envelope.

S1 (I) (September 23) graphic file with name 10.1177_1932296814536271-img1.jpg graphic file with name 10.1177_1932296814536271-img2.jpg
S1 (No I) (September 23) graphic file with name 10.1177_1932296814536271-img3.jpg graphic file with name 10.1177_1932296814536271-img4.jpg
S2 (I) (September 23) graphic file with name 10.1177_1932296814536271-img5.jpg graphic file with name 10.1177_1932296814536271-img6.jpg
S2 (No I) (September 23) graphic file with name 10.1177_1932296814536271-img7.jpg graphic file with name 10.1177_1932296814536271-img8.jpg

(Left) The reduced dynamic envelope generated from fasting data, with extraneous trajectories removed, shown for blood glucose (BG) (mg/dL) for September 23 with actual measurements superimposed (squares). Note that it enclosed the actual BG dynamics. (Right) Projected plasma insulin (PI) (pM), with actual PI shown (dashed blue line): (I) scenarios achieved prediction of blood insulin from fasting partial information, while (No I) scenarios predicted PI waveform as a function of underdetermined amplitude. (I), scenario where PI assays are available in stage 1 identification; (No I), scenario where PI assays are unavailable.